Operator of home health, hospice and senior living services through an independent, locally-managed operating model.
Operator of home health, hospice and senior living services through an independent, locally-managed operating model.
Paid mostly by Medicare, which sets fixed payment rates per 30-day period of home health care and per day of hospice care, so government rate-setting matters. Home health and hospice carry the business, with senior living paid privately by residents. It was spun off from Ensign Group in 2019.
Moat: narrow (distribution, scale). Decentralized local-leadership model drives operational focus, though scale remains smaller than national peers.
Headquarters: Eagle, Idaho · Founded: 2019 · Employees: 9,700
Size Pennant (PNTG) is a United States Health Care company (Medical/Nursing Services) with a market value of $1.26B, the 2087th largest of 3,085 United States companies the cockpit tracks. Shares closed at $35.81 on 18 Nov 2026.
Performance Over six months the shares gained 1.4%, against +17.1% for the median peer and -2.2% for the United States market (cap-weighted) — 7th lowest of 21 in its peer set.
Growth Revenue grew 38.7% over the last twelve months (peer median +7.9%); the operating margin is 6.2% (peer median 3.5%).
Valuation It trades at 23.7× forward earnings against a peer median of 29.4× (7th cheapest of 16).
Price implies For today's price to make sense, revenue must grow about 21% a year for seven years (Req g). Recent delivered growth is +19%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 3.6 points below its cost of capital (10.0% WACC).
Short interest Short interest is 3.3% of the free float (30 Oct 2026).
Next results Next results expected around 3 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $1.17B | $948M | $695M | $545M | $473M |
| Revenue growth | — | +36% | +28% | +15% | — |
| Gross profit | $153M | $122M | $87.6M | $61.9M | $53.7M |
| EBITDA | $85.1M | $65.6M | $44.3M | $30.8M | $25.4M |
| Net income | $35.9M | $29.6M | $22.6M | $13.4M | $6.64M |
| Free cash flow | $18.7M | $26.3M | $15.0M | $25.0M | -$5.13M |
| Capital expenditure | $45.8M | $22.0M | $20.4M | $8.11M | $14.2M |
| Total debt | $489M | $460M | $273M | $330M | $327M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Pennant PNTG | $1.26B | +1% | +39% | 6% | 23.7× | 20.7% |
| Addus HomeCare ADUS | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% |
| Brookdale Senior Living BKD | $2.06B | -36% | -8% | 6% | 482.6× | 19.3% |
| Encompass Health EHC | $13.2B | +27% | +9% | 18% | 20.1× | 5.7% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | PNTG | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -13.7% | +1.3% | 2nd lowest of 21 |
| 6-month return | +1.4% | +17.1% | 7th lowest of 21 |
| Distance from 52-week high | -19.1% | -23.8% | 9th highest of 21 |
| Revenue growth (TTM) | +38.7% | +7.9% | 2nd highest of 21 |
| Operating margin | 6.2% | 3.5% | 9th highest of 21 |
| Forward P/E | 23.7× | 29.4× | 7th cheapest of 16 |
| Growth the price implies (Req g, 7 yrs) | 20.7% | 8.5% | 3rd most demanding of 15 |
| Growth delivered (Del g) | +19.4% | +11.8% | 3rd highest of 15 |
| Hurdle (Req g minus delivered) | +1.4 pp | -0.4 pp | 7th most demanding of 15 |
| ROIC minus cost of capital | -3.6 pp | -3.6 pp | 10th highest of 19 |
| EV / EBITDA | 20.8× | 10.1× | 5th most expensive of 15 |
| Net debt / EBITDA | 5.5× | 1.3× | 4th most indebted of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Pennant PNTG | United States | $1.26B | +1% | +39% | 6% | 23.7× | 20.7% | +19.4% |
| OPKO Health OPK | United States | $1.25B | +37% | -22% | -29% | n/a | n/a | n/a |
| Metropolis Healthcare METROPOLIS.NS | India | $1.25B | +11% | +20% | 18% | 44.5× | 32.4% | +10.5% |
| Diagnostyka DIA.WA | Poland | $1.28B | -6% | +19% | 15% | 19.5× | 7.3% | +18.9% |
| Clariane CLARI.PA | France | $1.32B | -20% | +1% | 6% | 8.2× | 6.8% | +6.5% |
| Nutex Health NUTX | United States | $1.19B | +42% | -19% | 39% | 6.5× | -18.0% | +253.5% |
| Lumexa Imaging LMRI | United States | $1.35B | +89% | +8% | 2% | 16.0× | n/a | n/a |
| Ping An Healthcare and Technology 1833.HK | Hong Kong | $1.36B | -47% | +8% | 3% | 33.5× | 3.5% | -5.1% |
| GoodRx GDRX | United States | $1.15B | +33% | -2% | 12% | 10.6× | 6.3% | +7.7% |
| U.S. Physical Therapy USPH | United States | $1.42B | +53% | +10% | 10% | 29.4× | 18.8% | +13.0% |
| H.U.Group 4544.T | Japan | $1.44B | +24% | +1% | 3% | 39.9× | 9.7% | +2.1% |
| Teladoc Health TDOC | United States | $1.47B | +24% | -2% | -5% | n/a | -6.4% | +18.3% |
| agilon health AGL | United States | $1.52B | +12% | +2% | -2% | 34.1× | n/a | n/a |
| GeneDx WGS | United States | $1.56B | +16% | +15% | -14% | 54.2× | n/a | n/a |
| Novogene 688315.SS | China | $1.01B | +13% | +6% | 7% | 44.8× | 13.9% | +8.2% |
| AdaptHealth AHCO | United States | $1.01B | -30% | -3% | 3% | n/a | 16.8% | +25.2% |
| Ambea AMBEA.ST | Sweden | $1.59B | +28% | +11% | 9% | 15.2× | 1.1% | +7.7% |
| Sonida Senior Living SNDA | United States | $1.59B | -11% | +70% | -8% | n/a | n/a | n/a |
| Personalis PSNL | United States | $1.62B | +88% | +17% | -157% | n/a | n/a | n/a |
| Regis Healthcare REG.AX | Australia | $962M | -28% | +17% | 4% | 25.3× | 13.3% | +14.4% |
| Vijaya Diagnostic Centre VIJAYA.NS | India | $1.69B | +18% | +24% | 32% | 63.0× | 40.4% | +16.7% |